Cephalon Revises Fentora Labeling To Highlight Patient Selection Criteria Following Deaths

Among the deaths associated with the breakthrough cancer pain treatment were two patients prescribed the drug for migraines, Cephalon tells “The Pink Sheet” DAILY.